Bala Krishna Reddy Bhogala

Title: Innovations by Bala Krishna Reddy Bhogala

Introduction

Bala Krishna Reddy Bhogala is an accomplished inventor based in Kadapa, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative crystalline forms and co-crystals for various medical applications. With a total of 2 patents, his work is paving the way for advancements in treatment options for serious health conditions.

Latest Patents

His latest patents include the invention of crystalline forms of ibrutinib. This invention relates to several crystalline forms designated as Form S1, Form S2, Form S3, Form S4, and an amorphous form known as Form A1. These forms are crucial for the treatment of Bruton's tyrosine kinase (BTK) mediated diseases. Another notable patent is focused on ertugliflozin co-crystals, which involves processes for preparing ertugliflozin-L-pyroglutamic acid (1:1) and ertugliflozin-L-proline (1:1) co-crystals. This invention also includes an ertugliflozin-L-proline (1:2) co-crystal, which is significant for the treatment of type 2 diabetes mellitus.

Career Highlights

Bala Krishna Reddy Bhogala is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role in the company allows him to leverage his expertise in pharmaceutical innovations to contribute to the development of new therapeutic solutions.

Collaborations

He has collaborated with notable coworkers, including Ramkinkar Santra and Chandra Has Khanduri, who is a woman. These collaborations enhance the innovative capacity of his projects and contribute to the success of their collective research efforts.

Conclusion

Bala Krishna Reddy Bhogala's contributions to pharmaceutical innovations through his patents are noteworthy. His work not only addresses critical health issues but also exemplifies the importance of collaboration in advancing medical science.